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Background: Fanconi anemia is one of the best studied inherited cancer-prone diseases. Greatly improved protocols
for hematopoietic stem cell transplantation increasingly save the lives of these young patients. However, in both
transplanted and not transplanted patients, the emergence of aggressive squamous cell carcinoma represents a major
medical challenge.
Conclusions: This mini review summarizes current knowledge about the pathogenesis of squamous cell carcinoma
(SCC) in the special context of Fanconi anemia.
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Fanconi anemia is a rare inherited condition with an
incidence of approximately 1 in 200,000 births and a
median life expectancy in the mid-1920s. With the
exception of the X-chromosomal FANCB gene, biallelic
mutations in any of 15 FANC genes cause the recessive
multisystem disorder with highly variable clinical
presentation. In addition to progressive hematological
anomalies, 70% of FA patients display congenital anomalies
(including short stature, radial ray and renal defects, café au
lait spots, microphthalmia, and hearing difficulties). From a
clinical point of view, it is important to realize that 30% of
FA patients lack physical impairments although they share
the greatly increased risk of bone marrow failure, MDS,
AML, and squamous cell carcinomas (SCC). The clinical
suspicion of FA is confirmed by the demonstration of
increased spontaneous and induced chromosome breakage,
excessive accumulation of cells in the G2 phase of the cell
cycle, or targeted DNA sequencing. Symptomatic treatment
consists of blood product substitution and androgens, but
recent improvements render related or unrelated donor
HSCT the treatment of choice. Although curative with
respect to bone marrow failure, HSCT does not prevent
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1Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Children’s
Hospital, University Hospital of Düsseldorf, Moorenstr. 5, 40225 Düsseldorf,
Germany
Full list of author information is available at the end of the article
© 2014 Velleuer and Dietrich; licensee Springer
Commons Attribution License (http://creativeco
reproduction in any medium, provided the origIn a competing risk analysis, the estimated risk for the
development of any solid tumor by age 45 amounted to
75% [1,2]. The median age of onset of SCC in FA is
around 33 years, thus preceding that of the general
population by 30 to 40 years. Compared to the general
population, the overall risk is increased by 500- to
700-fold for head and neck SCC (HNSCC), 2,000-fold
for esophageal cancer, and 4,000-fold for vulvar cancer [3].
Most of the published and best studied SCC in FA
patients are located in the oral cavity [4].Clinical dilemma of HNSCC in FA
Compared to the non-FA population, two thirds of the
HNSCC in FA patients are located within the oral cavity,
most frequently at the tongue margins and the gingival
areas. In strong contrast to the non-FA (and mostly male)
population, these tumors arise in both male and female
FA patients without a prior history of excessive tobacco
and alcohol use [4]. Compared to untransplanted FA
patients, a history of HSCT (and a history of GvHD in
particular) increases the risk of HNSSC by 4.4-fold. In
transplanted patients, onset occurs approximately 10 years
earlier [5]. Sixty-three percent of patients present with late
stage and multiple tumors developing either synchronously
or metachronously [4].
Even if a patient presents at an early stage, there are
frequent relapses. The highly aggressive nature of the
tumors is reflected by poor survival, amounting to
less than 2 years [6]. Among published cases, 20% of. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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as the first sign of FA. To our knowledge, there is no
report in the FA literature validating the appearance
of potentially malignant disorders such as lichen planus,
erythroplakia, and leukoplakia. In our own experience
with more than 500 patients, these prodromal signs
appear to be quite frequent.
There is a limited number of reports describing the
epidemiology and natural history of FA-related SCC [2].
One of the most recent and largest collections of young
adult and adult FA patients affected by such tumors was
published by Grit Hohnbaum in 2008 [http://d-nb.info/
997016965]. As summarized in Figure 1, Hohnbaum
compiled data of 129 FA patients 20 years and older
(comprising 42 case reports from the literature (1964
to 2008), 36 case histories from newsletters of the
German and US FA family support groups (www.fanconi.
de and www.fanconi.org), and 51 FA patients with cell
cycle studies performed at the Institute of Human Genetics
of the University of Wurzburg, Germany). Overall, 60 of
these 129 patients (48 no HSCT, 12 after HSCT) developed
SCC during their lifetime. The average age at SCC
diagnosis for transplanted patients was 25.8 years (range
16 to 44 years) and for non-transplanted patients 30.0 years
(range 20 to 52 years).
Due to intrinsic genetic instability and hypersensitivity
towards DNA crosslinking agents in FA, treatment
options are limited, excluding standard protocols involving
cisplatinum. Surgery is the preferred option, but given the
frequently advanced tumor stage, additional treatments,
such as radiotherapy, are required. Given the pronounced
sensitivity of FA cells towards oxygen tension, it remains to
be seen whether hypoxic modification of the radiation
protocol may be of benefit for FA patients. Under hypoxic
(i.e., physiological) cell culture conditions, FA-derived
fibroblasts have been shown to tolerate ionizing radiation
as well as control cultures derived from unaffected donors
[7]. However, there are contradictory reports on in vivoFigure 1 Age of onset of SCC in FA patients with and without HSCT. Fo
(37.0%) developed SCC (average age at SCC diagnosis for 48 FA patien
Data summarized from Hohnbaum (see text).radiosensitivity of FA patients, with those tolerating up to
70 Gy without major problems, whereas other patients
suffer from severe side effects even at low-dose exposures
[8]. Patients with a favorable response to radiation may
represent mosaics (carrying somatic reversions of one of
their defective FA alleles in their blood cells). They may
also be carriers of the so-called ‘hypomorphic’ mutations
(presence of residual and functional FA protein in contrast
to ‘null’ mutations with complete absence of functional
FA protein). Whether transplanted patients tolerate
radiation therapy during SCC treatment better than
not transplanted patients requires further study. To
date, the use of alternative treatment options such as
epidermal growth factor inhibitors (e.g., cetuximab) is
slowly increasing in FA patients [8].
Cellular and molecular basis of HNSSC in FA
Whereas the increased susceptibility of FA patients to
early-onset SCC (largely in the absence of known external
risk factors) has been noted for decades, the question of
why the FA genotype is particularly prone to the develop-
ment of these particular types of tumors at quite specific
anatomical sites remains unanswered. Since many of the
known human genetic instability syndromes (including
ataxia telangiectasia, Bloom syndrome, and Werner syn-
drome) share the increased risk of early-onset neoplasia
with FA, there is little doubt that genetic instability per se
and intrinsically promotes carcinogenesis. Joenje et al.
have shown the rate of chromosomal breakage in FA cells
to be a clear function of the oxygen concentration in the
culture environment [9]. By growing FA cells under
hypoxic culture conditions (5% v/v oxygen), chromosomal
breakage can be all but eliminated. There is also in vivo
evidence for increased oxidative stress in FA, suggesting
an imbalance in the various cellular redox systems [10].
Since reactive oxygen species are known to damage
DNA, they are likely to contribute to carcinogenesis,
most plausibly in the absence of functional DNA repairrty-three of 83 female FA patients (51.8%) and 17 of 46 male FA patients
ts without HSCT 30.0 years, for 12 FA patients after HSCT 25.8 years).
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preferred anatomical sites at which SCC develop in
FA involve areas exposed to atmospheric oxygen (20% v/v
oxygen). However, clear evidence for a protective role of
the FA family of genes against oxygen toxicity is still
lacking.
Our current understanding of the role of the FA proteins
reflects their pivotal function in the surveillance and
maintenance of genomic integrity. As pointed out by
Romick-Rosendale and co-workers in a recent review
[11], the frequent emergence of SCC in FA must be seen
in the context of defective DNA repair compromising
genomic integrity. Owing to the rapid pace of FA gene
discovery during recent years, the eminent role of FA
proteins in recombinational types of DNA repair has
emerged (cf. Figure 2). Briefly, in response to crosslink
type of DNA damage and stalled replication forks,
eight of the known FA proteins assemble into the so-called
FA core complex which leads to the activation (via
monoubiquitination) of the FANCD2 and FANCI proteins
and, in turn, to the activation of a number of ‘downstream’
proteins instrumental in DNA repair. Interestingly,
monoallelic mutations in some of the downstream
proteins are known to confer a high risk of breast
cancer (e.g., FANCD1 = BRCA2, FANCN = PALPB2,
FANCJ = BRIP1, FANCO=RAD51C). Again, these obser-
vations emphasize the intimate connection between inad-
equate or failing DNA maintenance and the emergence of
neoplasia. Persistent or misrepaired DNA damage results in
cell cycle arrest, apoptosis, and chromosomal instability
and, ultimately, in the complex patterns of somatic
mutations and epimutations which characterize malignant
cell populations.
Role of FA proteins in sporadic cancers
Contrary to expectation, most studies of sporadic
cancers have shown the presence of intact and functioning
FA genes. This implies that the majority of tumor cells, atFigure 2 Simplified model of the Fanconi anemia pathway. Activation of
(orange circles) regulates downstream genes involved in recombination repaileast during the initial stages of tumor growth, require the
presence of intact FA genes. A frequently reported pre-
sumptive methylation defect (and thereby loss of function)
of the FANCF gene in many different types of cancers
could not be confirmed with improved technology [12].
Molecular alterations of a FA gene (FANCC) have been
observed in occasional sporadic SCC tumors, being
associated with higher recurrence rate and shorter
disease-free survival [13]. Given the highly complex
pattern of genetic alterations which, in advanced tumors,
may also involve members of the FA family of genes, these
limited observations cannot answer the question whether
alterations involving FA genes in a given tumor act as driver
or passenger mutations. The time- and stage-dependent
accumulation of genetic alterations, as evidenced by loss of
heterozygosity, suggests that a multistep process character-
izes the natural history of sporadic SCC [14]. Because of
the obviously intrinsic and highly aggressive nature of SCC
in FA patients, it was initially hoped to find differences in
the genetic makeup between FA and non-FA SCC cells.
However, a study by van Zeeburg et al. [15] involving 21
FA-derived SCC showed that the patterns of allelic loss
were similar to those observed in sporadic SCC.
Extrinsic factors which may promote HNSCC
development in FA
Excessive and long-term tobacco and alcohol consumption
have been clearly established as external factors in the
emergence of sporadic head and neck cancers, with tobacco
abuse being by far the major culprit in some studies
[16]. With regard to sporadic HNSCC, other proven
or suggestive associations have been described with
human papilloma virus (HPV) infection, with changes
in the oral microbiome, and with bad oral hygiene
culminating in chronic oral infections [11].
The important role of HPV is highlighted by the fact
that virus types 16 and 18 have been found in 25% of
sporadic HNSCC. Molecular studies have shown that anFANCD2 and FANCI by the FA core complex via monoubiquitination
r of DNA crosslinks.
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Vice versa, loss of a functional FA pathway is associated
with accumulation of E7, causing increased epithelial
proliferation and basal cell layer expansion in HPV-positive
epidermis [11]. There are important differences between
HPV-associated sporadic tumors and tumors arising in FA
patients: most HPV-positive sporadic tumors are located in
the oropharynx, whereas most FA-associated tumors are
located in the oral cavity. A similar difference holds for
gynecological tumors, with HPV-related tumors affecting
the cervix but FA-related tumors affecting the vulva and
anus. It therefore came as a surprise that a US study of
Kutler et al. [17] reported HPV in 84% of 25 SCC derived
from 24 FA patients. Likewise, 6 of 7 cancers of the vulva
and 15 of 18 HNSCC were found to be HPV positive. A
European study by van Zeeburg et al. was unable to
confirm these high rates of HPV in FA [15]. The
European authors detected HPV in only 2 of 21 FA-related
SCC (10%), with both positive cases involving the
anogenital regions. All 16 FA-derived HNSSCs were
negative. Technical and/or geographic/ethnic differences
between the two studies were extensively discussed, but
the controversy could not be resolved. Most recently,
Alter and co-workers published a smaller case series
involving nine tumors derived from FA patients in the US
[18]. In agreement with the van Zeeburg study, only a
single of the tumors was HPV positive, and the single
HPV-positive tumor originated from the anogenital area.
Collectively, the more recent studies suggest that HPV
infection may play a more prominent role in sporadic
compared to FA-related SCC. In addition, HPV-positive
sporadic tumors seem to have a better prognosis than
HPV-negative tumors. As mentioned before, SCC that
emerge on a FA genetic background are unusually
aggressive, are preferentially located in the oral cavity
rather than the oropharynx, and are more difficult to treat
because of the vulnerability of the FA genotype towards
crosslinking agents such as cisplatinum. Notwithstanding
these differences between sporadic and FA-related SCC
(implying differences in the pathogenesis of the respective
tumors), vaccination against HPV is generally recommended
for prepupertal FA patients of both sexes.
Environmental carcinogens
In contrast to the proven role of tobacco and alcohol
use in sporadic SCC, there is anecdotal evidence at best
for occasional smoking and/or drinking in young
adult FA patients. In a small study, there was no evidence
for excessive tobacco or alcohol use in FA patients
who develop SCC [4]. Larger epidemiological studies
are lacking.
Our experience with more than 500 interviewed FA
patients suggests that young adult FA patients tend to
consume alcohol in a social manner, quite comparableto the general population of the respective countries and
cultures. The social use of tobacco is clearly less common.
The carcinogenic effects of ethanol have only recently
been clarified. They appear to be mediated via acetaldehyde,
the first product of alcohol metabolism. On the basis of
these findings, the IARC working group rated acetaldehyde
derived from alcohol intake as a group I carcinogen. It was
further discovered that acetaldehydes generate DNA le-
sions, most notably DNA interstrand crosslinks, which lead
to activation of the FA pathway via monoubiquitination of
FANCD2. According to these studies, a functional FA path-
way is required for the proper elimination of DNA damage
induced by acetaldehyde. In addition to their obvious rele-
vance for the pathogenesis of the fetal alcohol syndrome,
these findings might also be relevant in the context of FA.
For example, a variety of aldehydes occur as natural by-
products of intermediary metabolism. Other moieties of
aldehydes, such as formaldehydes, are ubiquitously found
in the environment and may interfere with intrauterine and
postnatal development in a dose-dependent manner.
Murine transgenic models of FA rarely mimic all features
of the FA phenotype and thus are of limited use. However,
Langevin et al. recently succeeded in creating double
knockout mice in which both the FANCD2 alleles and the
alleles coding for alcohol dehydrogenase (Aldh2) were
inactivated (FancD2−/− plus Aldh2−/−) [19]. They found
that only Aldh2+/− mothers were able to give birth to
living FancD2−/− and Aldh2−/− offspring whereas
Aldh−/− mothers had no life offspring. The authors
suggest that only the mothers with at least one functioning
Aldh2 allele (Aldh2+/−) were able to detoxify aldehydes
generated in their offspring via the placenta. Most import-
antly, the surviving double knockout (FancD2−/−Aldh2−/−)
mice developed a typical FA phenotype with various malfor-
mations, progressive bone marrow failure, and death due to
leukemia. The authors went a step further and exposed the
pregnant Aldh+/− mice to a moderate dose of ethanol.
Most of their embryos died and the few survivors showed
severe malformations. A logical further step was to study
how FancD2−/−Aldh2−/− mice themselves react towards
exposure to ethanol in the drinking water. Most of the mice
succumbed to rapid bone marrow failure, emphasizing the
lack of protection towards the adverse effects of ethanol in
the absence of FANCD2 function. What about humans? A
recent study by Hira et al. [20] found accelerated bone
marrow failure in FA patient carriers of dominant-negative
ALDH2 alleles, confirming the adverse effects of ethanol
metabolism in the absence of a functioning FA pathway.
Oral health and the role of the microbiome
In addition to the main carcinogens tobacco and alcohol,
poor oral hygiene and negligent dental care have been
identified as possible risk factors for sporadic HNSCC.
These associations are thought to result from a shift
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genic inflammatory response setting the stage for chronic
inflammation.
In recent years, refined technologies such as 16S rRNA
analysis have facilitated whole-microbiome analysis.
Several such studies revealed differences in the composition
of the microbiota among tumor and non-tumor samples.
Whether the presence of different bacteria and/or the
disruption of the normal microbiome spectrum within the
mucosa contributes to carcinogenesis is worthy of further
investigation, including the HNSCC-prone population of
FA patients. It also seems worth to follow up on a recent
study suggesting that smoking may increase the ability of
the microbiome for the production of acetaldehydes [21].
According to this study, tobacco smoke might facilitate the
selection of microbes that are capable of a high rate of
acetaldehyde metabolism and thus would be more tolerant
to these compounds in heavy smokers. It should also be
mentioned that xylitol reduces the amount of acetaldehydes
produced by Candida albicans after ethanol exposure,
an observation that might bear potential therapeutic
and preventive implications [22]. The ability of bac-
teria and fungi to produce acetaldehydes highlights
the importance of good oral hygiene especially in FA
patients.
Summary
FA patients are at highly increased risk for early-onset
squamous cell carcinomas at specific locations (oral
cavity and anogenital area), regardless of whether they
have been transplanted or not. Reactive oxygen species,
DNA crosslinking agents, and aldehydes have been
identified as endogenous and exogenous sources of
DNA damage which, if un- or misrepaired, contributes
to carcinogenesis. Animal experiments have provided
evidence for the protective role of the FA pathway in the
detoxification of aldehyde compounds. It is strongly
recommended that FA patients avoid exogenous sources
of aldehydes. Even in the absence of a ‘typical FA pheno-
type,’ FA must be excluded by laboratory testing in
patients presenting with SCC at an early age and without
a history of excessive tobacco and alcohol use. Standard
treatment with crosslinking agents such as cisplatinum
would be fatal in unrecognized FA patients. This
includes the so-called ‘mosaic’ patients presenting with
normal blood counts and a negative chromosomal breakage
or cell cycle test. New therapeutic options like hypoxia-
modified radiation or epidermal growth factor inhibitors
might improve the poor prognosis of FA patients suffering
from advanced SCC. Most importantly, noninvasive screen-
ing options, including frequent self-examination and inspec-
tion by qualified care givers, should lead to early detection,
thus bearing the potential for the prevention of suffering
and premature death.Abbreviations
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